# Editorial: New Strategies to Combat Antimicrobial Resistance in Infectious Diseases

**Authors:** Antonia Efstathiou, Dimitra K. Toubanaki

PMC · DOI: 10.3390/ph19020274 · Pharmaceuticals · 2026-02-06

## Full-text entities

- **Genes:** beta-lactamase [NCBI Gene 18262323]
- **Diseases:** toxicity (MESH:D064420), biofilm-associated infections (MESH:D007239), COVID-19 (MESH:D000086382), Infectious Diseases (MESH:D003141), tuberculosis (MESH:D014376), AMR (MESH:D060467), Klebsiella pneumoniae (MESH:D007710), injury to (MESH:D014947)
- **Chemicals:** rifampicin (MESH:D012293), benzimidazole)-pyridine (-), flavonoids (MESH:D005419), reactive oxygen species (MESH:D017382), beta-lactam (MESH:D047090), meropenem (MESH:D000077731), avibactam (MESH:C543519)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Helcococcus kunzii (species) [taxon 40091], Bacteriophage sp. (species) [taxon 38018], Klebsiella pneumoniae (species) [taxon 573]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944676/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944676/full.md

---
Source: https://tomesphere.com/paper/PMC12944676